Assessing the Quality of Evidence From Randomized, Controlled Drug and Nutritional Supplement Trials Conducted Among Nursing Home Residents Between 1968 and 2004: What Can We Learn?

Journal of the American Medical Directors Association

Volumn 10, Issue 1, 2009, Pages 28-35

  Cheng, Huai Yong ^a  

^a Columbia University ^*  (United States)

Author keywords

drug; nursing homes; nutritional supplement; Randomized controlled trials

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CARBAMAZEPINE; CEFOPERAZONE; CEFTRIAXONE; CHLORHEXIDINE; COLECALCIFEROL; DONEPEZIL; ENEMA; ESTROGEN; GESTAGEN; GINSENG EXTRACT; GLYCEROL; LACTOSE; LACTULOSE; MEGESTROL ACETATE; NORFLOXACIN; NYSTATIN; OFLOXACIN; OLANZAPINE; PAROXETINE; RIMANTADINE; RISPERIDONE; SELEGILINE; SERTRALINE; TOPICAL AGENT; UNINDEXED DRUG; VALPROATE SEMISODIUM; VENLAFAXINE; ZANAMIVIR;

AGGRESSION; AGITATION; APPETITE; ARTICLE; BACTERIURIA; BEHAVIOR DISORDER; BODY WEIGHT; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DATA COLLECTION METHOD; DECUBITUS; DEPRESSION; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED NURSING; EXTERNAL VALIDITY; FRACTURE; FRUIT JUICE; HEALTH CARE QUALITY; HUMAN; INCONTINENCE; INFLUENZA; INTERNAL VALIDITY; MANIA; MEMORY DISORDER; NURSING CARE; NURSING HOME; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT SELECTION; PILOT STUDY; PNEUMONIA; POWER ANALYSIS; PRESCRIPTION; QUALITATIVE RESEARCH; QUANTITATIVE ANALYSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; SAMPLE SIZE; SIDE EFFECT; TREATMENT DURATION; UNITED STATES; URINARY TRACT INFECTION; VITAMIN SUPPLEMENTATION;

EID: 57849120621     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2008.06.005     Document Type: Article

References (82)

1. Sackett D.L., Rosenberg W.M.C., Gray J.A.M., et al. Evidence based medicine: What it is and what it isn't. BMJ 312 (1996) 71-72
2. Guyatt G.H., Haynes B., Jaeschke R.Z., et al. Users' guides to the medical literature: XXV. Evidence-based medicine: Principles for applying the users' guides to patient care. JAMA 284 (2000) 1290-1296
3. Mitka M. Too few older patients in cancer trials. JAMA 290 (2003) 27-28
4. Lee P.Y., Alexander K.P., Hammill B.G., et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 286 (2001) 708-713
5. Schmucker D.L., and Vesell E.S. Are the elderly underrepresented in clinical drug trials?. J Clin Pharmacol 39 (1999) 1103-1108
6. Cameron H.J., and Williams B.O. Clinical trials in the elderly. Should we do more?. Drugs Aging 9 (1996) 307-310
7. Gabrel C.S. Characteristics of elderly nursing home current residents and discharges: Data from the 1997 National Nursing homes Survey. Advance Data from vital and health statistics; no. 312 (2000), National Center for Health Statistics, Hyattsville, MD
8. Doshi J.A., Shaffer T., and Briesacher B.A. National estimates of medication use in nursing homes: Findings from the 1997 Medicare Current Beneficiary Survey and the 1996 Medical Expenditure Survey. J Am Geriatr Soc 53 (2005) 438-443
9. Messinger-Rapport B.J. Evidence-based medicine: is it relevant to long-term care?. J Am Med Dir Assoc 5 (2004) 328-332
10. Cheng H.Y. Evidence-based medicine in long-term care. J Am Med Dir Assoc 6 (2005) 168-169
11. Le Quintrec J.L., Bussy C., Golmard J.L., et al. Randomized controlled drug trials on very elderly subjects: Descriptive and methodological analysis of trials published between 1990 and 2002 and comparison with trials on adults. J Gerontol A Biol Sci Med Sci 60A (2005) 340-344
12. Epstein A.M. Paying for performance in the United States and abroad. N Eng J Med 355 (2006) 406-408
13. Robinson K.A., and Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol 31 (2002) 150-153
14. Meinert C.L., Tonascia S., and Higgins K. Content of reports on clinical trials: A critical review. Control Clin Trials 5 (1984) 328-347
15. Schulz K.F., Chalmers I., Grimes D.A., and Altman D.G. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 272 (1994) 125-128
16. Begg C., Cho M., Eastwood S., et al. Improving the quality of reporting of randomized controlled trials-The CONSORT statement. JAMA 276 (1996) 637-639
17. Altman D.G., Schulz K.F., Moher D., et al. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 134 (2001) 663-694
18. Jüni P., Altman D.G., and Egger M. Assessing the quality of controlled clinical trials. BMJ 323 (2001) 42-46
19. Gross C.P., Mallory R., Heiat A., and Krumholz H.M. Reporting the recruitment process in clinical trials: Who are these patients and how did they get there?. Ann Intern Med 137 (2002) 10-16
20. Sánchez-Thorin J.C., Cortés, Montenefro M., and Villate N. The quality of reporting of randomized clinical trials published in Ophthalmology. Ophthalmology 108 (2001) 410-415
21. Latronico N., Botteri M., Minelli C., et al. Quality of reporting of randomized controlled trials in the intensive care literature-a systemic analysis of papers published in Intensive Care Medicine. Intensive Care Med 28 (2002) 1316-1323
22. Moher D., Jadad A.R., Michol G., et al. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists. Controlled Clin Trials 16 (1995) 62-73
23. Jüni P., Witschi A., Bloch R., and Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282 (1999) 1054-1060
24. Guyatt G.H., Sackett D.L., Cook D.J., and Evidence-Based Medicine Working Group. User' guides to the medical literature, II. How to use an article about therapy or prevention. A. Are the results of the study valid?. JAMA 270 (1993) 2598-2601
25. Guyatt G.H., Sackett D.L., Cook D.J., and Evidence-Based Medicine Working Group. User' guides to the medical literature, II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients?. JAMA 271 (1994) 59-63
26. Dans A.L., Dans L.F., Guyatt G.H., Richardson S., and Evidence-Based Medicine Working Group. User' guides to the medical literature, XIV. How to decide on the applicability of clinical trial results to your patient. JAMA 279 (1998) 545-549
27. Britton A., McKee M., Black N., et al. Threats to applicability of randomized trials: Exclusions and selective participation. J Health Serv Res Policy 4 (1999) 112-121
28. Shepherd J., Blauw G.J., Murphy M.B., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomized controlled trial. Lancet 360 (2002) 1623-1630
29. Chan A.W., and Altman D.G. Epidemiology and reporting of randomized trials published in PubMed journals. Lancet 365 (2005) 1159-1162
30. Stephan F., Gøtzsche M., and Gøtzsche P.C. Sample size of randomized double-blind trials 1976-1991. Dan Med Bull 43 (1996) 96-98
31. Moher D., Dulberg C.S., and Wells G.A. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 272 (1994) 122-124
32. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. BMJ 2 (1948) 769-782
33. Bravo D., Dubois M.F., Hébert R., et al. A prospective evaluation of the Charlson Comorbidity Index for use in long-term care patients. J Am Geriatr Soc 50 (2002) 740-745
34. Altman D.G. Poor-quality medical research-What can journals do?. JAMA 287 (2002) 2765-2767
35. Altman D.G. The scandal of poor medical research. BMJ 308 (1994) 283-284
36. Moher D., Jones A., Lepage L., and CONSORT group. Use of the CONSORT statement and quality of reports randomized trials-A comparative before-and-after evaluation. JAMA 285 (2001) 1992-1995
37. Dolinar R.O., and Leininger S.L. Pay for performance means compliance-based care. J Am Med Dir Assoc 7 (2006) 328-333
38. Boyd C.M., Darer J., Bout C., et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases-Implications for Pay for Performance. JAMA 294 (2005) 716-724
39. Bhandari M., Busse J.W., Jackowski D., et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 170 (2004) 477-480
40. Kennedy D. The old file-drawer problem. Science 305 (2004) 451
41. Meydani S.N., Leka L.S., Fine B.S., et al. Vitamin E and respiratory tract infections in elderly nursing home residents- a randomized controlled trial. JAMA 292 (2004) 828-836
42. Meguro K., Meguro M., Tanaka Y., et al. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease. J Geriatr Psychiatry Neurol 17 (2004) 61-67
43. McElbaney J.E., Granvenstein S., Cole S.K., et al. A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. J Am Geriatr Soc 52 (2004) 13-19
44. Landi F., Aloe L., Russo A., et al. Topical treatment of pressure ulcers with nerve growth factor-a randomized clinical trial. Ann Intern Med 139 (2003) 635-641
45. Brodaty H., Ames D., Snowdon J., et al. A randomized placebo-controlled trial of resperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 64 (2003) 134-143
46. Oslin D.W., Ten Have T.R., Streim J.E., et al. Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. J Clin Psychiatry 64 (2003) 875-882
47. Fontanine C.S., Hynan L.S., Koch K., et al. A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities. J Clin Psychiatry 64 (2003) 726-730
48. Burrows A.B., Salzman C., Satlin A., et al. A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression. Depression and Anxiety 15 (2002) 102-110
49. Meyer H.E., Smedshaug G.B., Kvaavik E., et al. Can vitamin D supplementation reduce the risk of fracture in the elderly?. A randomized controlled trial. JBMR 17 (2002) 709-715
50. Wouters-Wesseling W., Wouters A.E.J., Kleijer C.N., et al. Study of the effect of a liquid nutrition supplement on the nutritional status of psycho-geriatric nursing home patients. European J Clin Nutrition 56 (2002) 245-251
51. Tariot P.N., Cummings J.L., Katz I.R., et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc 49 (2001) 1590-1599
52. Ouslander J.G., Greendale G.A., Uman G., et al. Effect of oral estrogen and progestin on the lower urinary tract among female nursing home residents. J Am Geriatr Soc 49 (2001) 803-807
53. Rhodes R.S., Heyneman C.A., Culbertson V.L., et al. Topical phenytoin treatment of satge II decubitus ulcers in the elderly. Ann Pharmacther 35 (2001) 675-681
54. Porsteinsson A.P., Tariot P.N., Erb R., et al. Placebo-controlled study of divalproex sodium for agitation in dementia. Am J Geriatr Psychiatry 9 (2001) 58-66
55. Tariot P.N., Schneider L.S., Mintzer J.E., et al. Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial. Current Therapeutic Research 62 (2001) 51-67
56. Kwok T., Woo J., and Kwan M. Does low lactose mild power improve the nutritional intake and nutritional status of frail older Chinese people living in nursing homes?. J Nutrition, Health & Aging 5 (2001) 17-21
57. Yeh S.S., Wu S.Y., Lee T.P., et al. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study. J Am Geriatr Soc 48 (2000) 485-492
58. Oslin D.W., Streim J.E., Katz I.R., et al. Heuristic comparison of sertraline with nortriptyline for the treatment of depression in frail elderly patients. Am J Geriatr Psychiatry 8 (2000) 141-149
59. Magai C., Kennedy G., Cohen C.I., and Gomberg D. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease. Am J Geriatr Psychiatry 8 (2000) 66-74
60. Lauque S., Arnaud-Battandier F., Mansourian R., et al. Protein-energy oral supplementation in malnourished nursing-home residents. A controlled trial. Age and Ageing 29 (2000) 51-56
61. Street J.S., Clark W., Gannon K.S., et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities. Arch Gen Psychiatry 57 (2000) 968-976
62. Singh M.A.F., Bernstein M.A., Ryan N.D., et al. The effect of oral nutritional supplements on habitual dietary quality and quantity in frail elders. Journ of Nutr Health & Aging 1 (2000) 5-12
63. Chassagne P., Jego A., Gloc P., et al. Does treatment of constipation improve faecal incontinence in institutionalized elderly patients?. Age and Ageing 29 (2000) 159-164
64. Filip V., and Kolibás E. Selgiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. J Psychiatry Neurosci 24 (1999) 234-243
65. Schilling M., Povine L., Krause P., et al. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks. Vaccine 16 (1998) 1771-1774
66. Tariot P.N., Erb R., Podgorski C.A., et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 155 (1998) 54-61
67. Galan P., Preziosi P., Monget A.L., et al. Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metobolism and immunological markers in elderly long term-hospitalized subjects. Internat J Vit Nutr Res 67 (1997) 450-460
68. Monget A.L., Richard M.J., Cournot M.P., et al. Effect of 6 month supplementation with different combinations of an association of antitoxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. European J Clin Nutrition (1996) 443-449
69. Nicolle L.E., Kirshen A., Boustcha E., and Montgomery P. Treatment of moderate-to-severe pneumonia in elderly, long-term care facility residents. Infectious Diseases in Clinical Practice 5 (1996) 130-137
70. Monto A.S., Ohmit S.E., Hornbuckle K., et al. Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes. Antimicrob Agents Chemother 39 (1995) 2224-2228
71. van der Wielen R.P.J., van Heereveld H.A.E.M., de Groot C.P.G.M., and van Staveren W.A. Nutritional status of elderly female nursing home residents; the effect of supplementation with a physiological dose of water-soluble vitamins. European J Clin Nutrition 49 (1995) 665-674
72. McCue J.D., Gaziano P., and Orders D. A randomized controlled trial of ofloxacin 200mg 4 times daily or twice daily vs ciprofloxacin 500mg twice daily in elderly nursing home patients with complicated UTI. Drugs 49 Suppl. 2 (1995) 368-373
73. Banting D.W., Greeenorn P.A., and McMinn J.G. Effectiveness of a topical antifungal regimen for the treatment of oral candiaiasis in older, chronically ill, institutionalized, adults. J Can Dent Assoc 61 (1995) 199-200 203-2-5
74. Ouslander J.G., Shapira M., Schnelle J.F., et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents?. Ann Intern Med 122 (1995) 749-754
75. Clark D.C., and Guest J.L. The effectiveness of three different strengths of chlorhexidine mouthrinse. Journal-Canadian Dental Association 60 (1994) 711-714
76. Phillips S.L., and Branaman-Phillips J. The use of intramuscular cefoperazone versus intramuscular ceftraxone in patients with nursing home-acquired pneumonia. J Am Geriatr Soc 41 (1993) 1071-1074
77. Murphy S., West Jr. K.P., Greenough III W.B., et al. Impact of vitamin A supplementation on the incidence of infection in elderly nursing-home residents: a randomized controlled trial. Age and Ageing 21 (1992) 435-439
78. Gerding G.A., and Browning J.S. Oxyquinoline-contaning ointment vs. standard therapy for stage I and stage II skin lesions. Dermatology Nursing 4 (1992) 389-398
79. Hirata-Dulas C.A., Stein D.J., Guay D.R.P., et al. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. J Am Geriatr Soc 39 (1991) 979-985
80. Himmelstein S., Clemens T.L., Rubin A., and Lindsay R. Vitamin D supplementation in elderly nursing home residents increase 25(OH) D but not 1,25 (OH)2 D. Am J Clin Nutr 52 (1990) 701-706
81. Nicolle L.E., Mayhew W.J., and Bryan L. Prospective randomized comparison of therapy and no therapy for aymptomatic bacteria in institutionalized elderly women. Am J Med 83 (1987) 27-33
82. Gaitz C.M., Varner R.V., and Overall J.E. Pharmacothrapy for organic brain syndrome in late life. Arch Gen Psychiatry 34 (1977) 839-845